Home
De nobis
De Gentolex
Factory Tour
Culture
FAQs
Products
Chemicals
Intermedia chemica
Chemicals Organic
Inorganics Chemicals
catalysts et Auxiliares
Pharma Ingredients
Pharma APIs
Anti-infectivum
Ratio cardiovascularis
Alia Apis
Systema generationis
Secretio System
Pharma Intermedia
Amino acida
Cosmetics Peptide
Service
Procurement Service
CRO&CDMO
News CELLA
Nobis loquere
English
Home
News
News
Venditio comparationis Dulaglutide, Liraglutide et Semaglutide.
by admin on 22-07-25
Pharmaceuticus gigas Lilium, societas Americana, et Novo Nordiscus, societas Danica, successive nuntiaverunt venditiones notitiarum praecipuarum eorum in anno 2020: Dulaglutide facta est TOP1 GLP-1 d...
Lege plus
An incrementum hormone tardus vel accelerat senescit?
by admin on 22-07-22
GH/IGF-1 physiologice cum aetate decrescit, et hae mutationes cum lassitudine, atrophia musculi, textus adipositi augentur, ac depravatio in senibus cognitiva… Anno 1990, Rudma...
Lege plus
New Products Alert
by admin on 22-07-21
Ut plures optiones clientibus in Cosmetica peptidis industriae praebeant, Gentolex novos fructus in indice continenter addet.Qualitas cum varietate praedicamentorum, sunt prorsus quattuor...
Lege plus
Acadia Trofinetide Phase III Fusce Top-Line Proventus Positivus
by on 22-02-17
Die 2021-12-06, tempore US, Acadia pharmaceutica (Nasdaq: ACAD) nuntiavit eventus positivus top-lineus sui Phase III clinici iudicii sui medicamentorum candidatorum Trofinetide.Pascha III iudicium vocatur.
Lege plus
Progressus investigationis peptidum opioideorum ex approbatione Difelikefalin
by on 22-02-17
Cum diluculo ad 2021-08-24, Cara Therapeutica et socium suum negotium Vifor Pharma nuntiavit suum primum in classe Kappa opioidem receptam agonist difelikefalin (KORSUVA™) a FDA approbatam esse.
Lege plus
RhoVac Cancer Peptide Vaccine RV001 patentes a Canadian Intellectual Property Office
by on 22-02-17
Canada tempus 2022-01-24, RhoVac, societas pharmaceutica ad immunologiam tumorem tendit, nuntiavit applicationem eius patentem (No. 2710061) pro suo cancro peptide vaccino RV001 auctoritate .. .
Lege plus
Intrare quaerere vel ESC claudere
English
French
German
Portuguese
Spanish
Russian
Japanese
Korean
Arabic
Irish
Greek
Turkish
Italian
Danish
Romanian
Indonesian
Czech
Afrikaans
Swedish
Polish
Basque
Catalan
Esperanto
Hindi
Lao
Albanian
Amharic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Bulgarian
Cebuano
Chichewa
Corsican
Croatian
Dutch
Estonian
Filipino
Finnish
Frisian
Galician
Georgian
Gujarati
Haitian
Hausa
Hawaiian
Hebrew
Hmong
Hungarian
Icelandic
Igbo
Javanese
Kannada
Kazakh
Khmer
Kurdish
Kyrgyz
Latin
Latvian
Lithuanian
Luxembou..
Macedonian
Malagasy
Malay
Malayalam
Maltese
Maori
Marathi
Mongolian
Burmese
Nepali
Norwegian
Pashto
Persian
Punjabi
Serbian
Sesotho
Sinhala
Slovak
Slovenian
Somali
Samoan
Scots Gaelic
Shona
Sindhi
Sundanese
Swahili
Tajik
Tamil
Telugu
Thai
Ukrainian
Urdu
Uzbek
Vietnamese
Welsh
Xhosa
Yiddish
Yoruba
Zulu
Kinyarwanda
Tatar
Oriya
Turkmen
Uyghur